Importance of the functional sensitivity determination of a serum hyaluronic acid assay for the prediction of liver fibrosis in patients with features of the metabolic syndrome [3]

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 4, 2006, Pages 505-507

  Massart, Catherine ^a,b   Bendavid, Claude ^b   Gibassier, Jacqueline ^a   Perrin, Michèle ^c   Deugnier, Yves ^a,c   Lainé, Fabrice ^a,c  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Enzyme liked immunosorbent assay; Functional sensitivity; Hyaluronic acid; Liver fibrosis

Indexed keywords

HYALURONIC ACID;

ACCURACY; CALCULATION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL ASSESSMENT; HUMAN; IMMUNOASSAY; INFORMATION; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; METABOLIC SYNDROME X; PREDICTION; PRIORITY JOURNAL; RADIOMETRY; SENSITIVITY ANALYSIS; SERUM;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYALURONIC ACID; LIVER CIRRHOSIS; METABOLIC SYNDROME X; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 33645792638     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.076     Document Type: Letter

References (17)

1. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997;242:27-33.
2. Wong VS, Hugues V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat 1998;5:187-92.
3. McHutchison JG, Blatt LM, De Medina M, Craig JR, Conrad A, Schiff ER, et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. J Gastrol Hepatol 2000;15:945-51.
4. Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005;51:1867-73.
5. Plevris JN, Haydon GH, Simpson KJ, Dawkes R, Ludlum CA, Harrison DJ, et al. Serum hyaluronan - a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol 2000;12:1121-7.
6. Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M, Caballeria J, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996;24:1399-403.
7. Lainé F, Bendavid C, Moirand R, Tessier S, Perrin M, Guillygomarc'h, et al. Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption. Hepatology 2004;39:1639-46.
8. Laurent UB, Tengblad A. Determination of hyaluronate in biological samples by a specific radioassay technique. Anal Biochem 1980;109:386-94.
9. Fosang AJ, Hey NJ, Carney SL, Hardingham TE. An ELISA plate-based assay for hyaluronan using biotinylated proteoglycan G1 domain (HA-binding region). Matrix 1990;10:306-13.
10. Lindqvist U, Chichibu K, Delpech B, Goldberg RL, Knudson W, Poole R, et al. Seven different assays of hyaluronan compared for clinical utility. Clin Chem 1992;38:127-32.
11. Grigoreas GH, Anagnostides ST, Vynios DH. A solid-phase assay for the quantitative analysis of hyaluronic acid at the nanogram level. Anal Biochem 2003;320:179-84.
12. Spencer CA, Takeuchi M, Kararosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996;43:140-5.
13. Taieb J, Benattar C, Birr AS, Lindenbaum A. Limitations of steroid determination by direct immunoassay. Clin Chem 2002;48:583-5.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
15. Buttner J. Philosophy of measurement by means of immunoassays [review]. Scand J Clin Lab Invest 1991;205:11-20.
16. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine [review]. Clin Chem 1993;39:561-77.
17. Lainé F, Bendavid C, Morcet J, Perrin M, Massart C, Deugnier Y. Reassessment of the algorithm for prediction of liver fibrosis in patients with features of the metabolic syndrome. Hepatology 2006;43:377-8.